25 XP   0   0   10

CStone Pharmaceuticals
Buy, Hold or Sell?

Let's analyse CStone Pharmaceuticals together

PenkeI guess you are interested in CStone Pharmaceuticals. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of CStone Pharmaceuticals. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about CStone Pharmaceuticals

I send you an email if I find something interesting about CStone Pharmaceuticals.

Quick analysis of CStone Pharmaceuticals (30 sec.)










What can you expect buying and holding a share of CStone Pharmaceuticals? (30 sec.)

How much money do you get?

How much money do you get?
HK$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
HK$0.38
Expected worth in 1 year
HK$-2.18
How sure are you?
57.1%

+ What do you gain per year?

Total Gains per Share
HK$-2.55
Return On Investment
-283.8%

For what price can you sell your share?

Current Price per Share
HK$0.90
Expected price per share
HK$0.8 - HK$1.35
How sure are you?
50%

1. Valuation of CStone Pharmaceuticals (5 min.)




Live pricePrice per Share (EOD)

HK$0.90

Intrinsic Value Per Share

HK$-8.93 - HK$-2.17

Total Value Per Share

HK$-8.55 - HK$-1.79

2. Growth of CStone Pharmaceuticals (5 min.)




Is CStone Pharmaceuticals growing?

Current yearPrevious yearGrowGrow %
How rich?$62m$166.6m-$104.6m-168.6%

How much money is CStone Pharmaceuticals making?

Current yearPrevious yearGrowGrow %
Making money-$115.2m-$245.1m$129.9m112.7%
Net Profit Margin-187.5%-787.8%--

How much money comes from the company's main activities?

3. Financial Health of CStone Pharmaceuticals (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#454 / 1016

Most Revenue
#140 / 1016

Most Profit
#983 / 1016

Most Efficient
#631 / 1016

What can you expect buying and holding a share of CStone Pharmaceuticals? (5 min.)

Welcome investor! CStone Pharmaceuticals's management wants to use your money to grow the business. In return you get a share of CStone Pharmaceuticals.

What can you expect buying and holding a share of CStone Pharmaceuticals?

First you should know what it really means to hold a share of CStone Pharmaceuticals. And how you can make/lose money.

Speculation

The Price per Share of CStone Pharmaceuticals is HK$0.9. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of CStone Pharmaceuticals.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in CStone Pharmaceuticals, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is HK$0.38. Based on the TTM, the Book Value Change Per Share is HK$-0.64 per quarter. Based on the YOY, the Book Value Change Per Share is HK$-1.47 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is HK$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of CStone Pharmaceuticals.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 HK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per Share
Usd Eps-0.09-10.0%-0.09-10.0%-0.19-21.2%-0.13-14.6%-0.10-10.8%
Usd Book Value Change Per Share-0.08-9.1%-0.08-9.1%-0.19-20.9%0.000.0%0.010.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.08-9.1%-0.08-9.1%-0.19-20.9%0.000.0%0.010.8%
Usd Price Per Share0.59-0.59-1.06-0.85-0.61-
Price to Earnings Ratio-6.58--6.58--5.53--5.82--4.16-
Price-to-Total Gains Ratio-7.25--7.25--5.62-4.66-4.66-
Price to Book Ratio12.23-12.23-8.13-5.87-4.19-
Price-to-Total Gains Ratio-7.25--7.25--5.62-4.66-4.66-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.11493
Number of shares8700
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.080.00
Usd Total Gains Per Share-0.080.00
Gains per Quarter (8700 shares)-709.37-0.32
Gains per Year (8700 shares)-2,837.47-1.29
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-2837-28470-1-11
20-5675-56840-3-12
30-8512-85210-4-13
40-11350-113580-5-14
50-14187-141950-6-15
60-17025-170320-8-16
70-19862-198690-9-17
80-22700-227060-10-18
90-25537-255430-12-19
100-28375-283800-13-20

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.07.00.00.0%0.07.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%4.03.00.057.1%4.03.00.057.1%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.07.00.0%0.00.07.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%4.03.00.057.1%4.03.00.057.1%

Fundamentals of CStone Pharmaceuticals

About CStone Pharmaceuticals

CStone Pharmaceuticals, a biopharmaceutical company, researches, develops, and commercializes immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and internationally. It offers Sugemalimab, a monoclonal antibody against programmed death (PD) ligand 1; GAVRETO, an RET inhibitor for the treatment of patients with advanced or metastatic RET-mutant medullary and RET fusion-positive thyroid cancers; and avapritinib, a KIT/PDGFRA inhibitor to treat adults with unresectable or metastatic gastrointestinal stromal tumors harboring a PDGFRA exon 18 mutation. The company's product pipeline includes Nofazinlimab, a PD-1 antibody for the treatment of patients with hepatocellular carcinoma; and Ivosidenib, an isocitrate dehydrogenase 1 (IDH1) inhibitor to treat adults with relapsed or refractory acute myeloid leukemia with an IDH1 mutation. Its products also comprise CS1002, CS2006, CS3005, CS2007, CS2008, CS6001, and CS500 for solid tumors; and CS5001 for solid tumors and hematologic malignancies. The company was incorporated in 2015 and is headquartered in Suzhou, China.

Fundamental data was last updated by Penke on 2024-04-16 08:59:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of CStone Pharmaceuticals.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit CStone Pharmaceuticals earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare CStone Pharmaceuticals to the Biotechnology industry mean.
  • A Net Profit Margin of -187.5% means that $-1.88 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of CStone Pharmaceuticals:

  • The MRQ is -187.5%. The company is making a huge loss. -2
  • The TTM is -187.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-187.5%TTM-187.5%0.0%
TTM-187.5%YOY-787.8%+600.3%
TTM-187.5%5Y-218.6%+31.1%
5Y-218.6%10Y-584.6%+366.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-187.5%-199.6%+12.1%
TTM-187.5%-213.0%+25.5%
YOY-787.8%-279.3%-508.5%
5Y-218.6%-438.4%+219.8%
10Y-584.6%-605.5%+20.9%
1.1.2. Return on Assets

Shows how efficient CStone Pharmaceuticals is using its assets to generate profit.

  • Above 5% is considered healthy but always compare CStone Pharmaceuticals to the Biotechnology industry mean.
  • -50.9% Return on Assets means that CStone Pharmaceuticals generated $-0.51 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of CStone Pharmaceuticals:

  • The MRQ is -50.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -50.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-50.9%TTM-50.9%0.0%
TTM-50.9%YOY-78.2%+27.2%
TTM-50.9%5Y-66.1%+15.1%
5Y-66.1%10Y-58.4%-7.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-50.9%-13.5%-37.4%
TTM-50.9%-12.9%-38.0%
YOY-78.2%-11.8%-66.4%
5Y-66.1%-14.1%-52.0%
10Y-58.4%-16.0%-42.4%
1.1.3. Return on Equity

Shows how efficient CStone Pharmaceuticals is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare CStone Pharmaceuticals to the Biotechnology industry mean.
  • -185.8% Return on Equity means CStone Pharmaceuticals generated $-1.86 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of CStone Pharmaceuticals:

  • The MRQ is -185.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -185.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-185.8%TTM-185.8%0.0%
TTM-185.8%YOY-147.1%-38.7%
TTM-185.8%5Y-154.0%-31.7%
5Y-154.0%10Y-124.2%-29.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-185.8%-16.9%-168.9%
TTM-185.8%-16.1%-169.7%
YOY-147.1%-15.1%-132.0%
5Y-154.0%-19.9%-134.1%
10Y-124.2%-20.9%-103.3%

1.2. Operating Efficiency of CStone Pharmaceuticals.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient CStone Pharmaceuticals is operating .

  • Measures how much profit CStone Pharmaceuticals makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare CStone Pharmaceuticals to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of CStone Pharmaceuticals:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-750.6%+750.6%
TTM-5Y-170.6%+170.6%
5Y-170.6%10Y-458.2%+287.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--295.1%+295.1%
TTM--225.8%+225.8%
YOY-750.6%-288.4%-462.2%
5Y-170.6%-477.4%+306.8%
10Y-458.2%-625.6%+167.4%
1.2.2. Operating Ratio

Measures how efficient CStone Pharmaceuticals is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 3.30 means that the operating costs are $3.30 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of CStone Pharmaceuticals:

  • The MRQ is 3.299. The company is inefficient in keeping operating costs low. -1
  • The TTM is 3.299. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ3.299TTM3.2990.000
TTM3.299YOY8.797-5.498
TTM3.2995Y2.871+0.428
5Y2.87110Y5.413-2.543
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.2993.090+0.209
TTM3.2993.264+0.035
YOY8.7973.783+5.014
5Y2.8715.679-2.808
10Y5.4137.894-2.481

1.3. Liquidity of CStone Pharmaceuticals.

1.3. Liquidity
1.3.1. Current Ratio

Measures if CStone Pharmaceuticals is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.32 means the company has $1.32 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of CStone Pharmaceuticals:

  • The MRQ is 1.317. The company is just able to pay all its short-term debts.
  • The TTM is 1.317. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.317TTM1.3170.000
TTM1.317YOY2.098-0.781
TTM1.3175Y3.216-1.899
5Y3.21610Y4.976-1.760
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3173.914-2.597
TTM1.3174.220-2.903
YOY2.0985.388-3.290
5Y3.2166.045-2.829
10Y4.9766.406-1.430
1.3.2. Quick Ratio

Measures if CStone Pharmaceuticals is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare CStone Pharmaceuticals to the Biotechnology industry mean.
  • A Quick Ratio of 1.84 means the company can pay off $1.84 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of CStone Pharmaceuticals:

  • The MRQ is 1.841. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.841. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.841TTM1.8410.000
TTM1.841YOY3.031-1.190
TTM1.8415Y4.332-2.491
5Y4.33210Y6.517-2.185
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8413.572-1.731
TTM1.8413.998-2.157
YOY3.0315.390-2.359
5Y4.3325.969-1.637
10Y6.5176.287+0.230

1.4. Solvency of CStone Pharmaceuticals.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of CStone Pharmaceuticals assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare CStone Pharmaceuticals to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.73 means that CStone Pharmaceuticals assets are financed with 72.6% credit (debt) and the remaining percentage (100% - 72.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of CStone Pharmaceuticals:

  • The MRQ is 0.726. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.726. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.726TTM0.7260.000
TTM0.726YOY0.469+0.257
TTM0.7265Y0.450+0.275
5Y0.45010Y0.361+0.090
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7260.336+0.390
TTM0.7260.334+0.392
YOY0.4690.269+0.200
5Y0.4500.366+0.084
10Y0.3610.390-0.029
1.4.2. Debt to Equity Ratio

Measures if CStone Pharmaceuticals is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare CStone Pharmaceuticals to the Biotechnology industry mean.
  • A Debt to Equity ratio of 264.6% means that company has $2.65 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of CStone Pharmaceuticals:

  • The MRQ is 2.646. The company is unable to pay all its debts with equity. -1
  • The TTM is 2.646. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ2.646TTM2.6460.000
TTM2.646YOY0.882+1.765
TTM2.6465Y1.232+1.415
5Y1.23210Y0.930+0.302
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6460.382+2.264
TTM2.6460.396+2.250
YOY0.8820.335+0.547
5Y1.2320.434+0.798
10Y0.9300.465+0.465

2. Market Valuation of CStone Pharmaceuticals

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings CStone Pharmaceuticals generates.

  • Above 15 is considered overpriced but always compare CStone Pharmaceuticals to the Biotechnology industry mean.
  • A PE ratio of -6.58 means the investor is paying $-6.58 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of CStone Pharmaceuticals:

  • The EOD is -1.280. Based on the earnings, the company is expensive. -2
  • The MRQ is -6.583. Based on the earnings, the company is expensive. -2
  • The TTM is -6.583. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.280MRQ-6.583+5.303
MRQ-6.583TTM-6.5830.000
TTM-6.583YOY-5.528-1.055
TTM-6.5835Y-5.819-0.764
5Y-5.81910Y-4.156-1.663
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.280-2.259+0.979
MRQ-6.583-2.569-4.014
TTM-6.583-2.664-3.919
YOY-5.528-4.120-1.408
5Y-5.819-6.258+0.439
10Y-4.156-6.171+2.015
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of CStone Pharmaceuticals:

  • The EOD is -1.495. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -7.692. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -7.692. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.495MRQ-7.692+6.197
MRQ-7.692TTM-7.6920.000
TTM-7.692YOY-6.009-1.683
TTM-7.6925Y-9.106+1.415
5Y-9.10610Y-6.505-2.602
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.495-2.924+1.429
MRQ-7.692-3.246-4.446
TTM-7.692-3.488-4.204
YOY-6.009-5.620-0.389
5Y-9.106-8.315-0.791
10Y-6.505-8.826+2.321
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of CStone Pharmaceuticals is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 12.23 means the investor is paying $12.23 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of CStone Pharmaceuticals:

  • The EOD is 2.377. Based on the equity, the company is underpriced. +1
  • The MRQ is 12.228. Based on the equity, the company is expensive. -2
  • The TTM is 12.228. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD2.377MRQ12.228-9.851
MRQ12.228TTM12.2280.000
TTM12.228YOY8.131+4.097
TTM12.2285Y5.866+6.361
5Y5.86610Y4.190+1.676
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.3771.851+0.526
MRQ12.2282.090+10.138
TTM12.2282.095+10.133
YOY8.1312.844+5.287
5Y5.8663.466+2.400
10Y4.1903.815+0.375
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of CStone Pharmaceuticals compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.639-0.6390%-1.473+131%0.000-100%0.054-1280%
Book Value Per Share--0.3790.3790%1.017-63%1.282-70%1.062-64%
Current Ratio--1.3171.3170%2.098-37%3.216-59%4.976-74%
Debt To Asset Ratio--0.7260.7260%0.469+55%0.450+61%0.361+101%
Debt To Equity Ratio--2.6462.6460%0.882+200%1.232+115%0.930+185%
Dividend Per Share----0%-0%-0%-0%
Eps---0.703-0.7030%-1.496+113%-1.026+46%-0.758+8%
Free Cash Flow Per Share---0.602-0.6020%-1.376+129%-0.812+35%-0.636+6%
Free Cash Flow To Equity Per Share---0.578-0.5780%-1.298+125%0.075-869%0.119-585%
Gross Profit Margin--1.0001.0000%1.0000%1.023-2%1.017-2%
Intrinsic Value_10Y_max---2.167--------
Intrinsic Value_10Y_min---8.927--------
Intrinsic Value_1Y_max---0.685--------
Intrinsic Value_1Y_min---0.849--------
Intrinsic Value_3Y_max---1.702--------
Intrinsic Value_3Y_min---2.606--------
Intrinsic Value_5Y_max---2.289--------
Intrinsic Value_5Y_min---4.408--------
Market Cap1155032985.600-414%5942003025.9205942003025.9200%10613469767.680-44%8542110613.504-30%6101507581.074-3%
Net Profit Margin---1.875-1.8750%-7.878+320%-2.186+17%-5.846+212%
Operating Margin----0%-7.5060%-1.7060%-4.5820%
Operating Ratio--3.2993.2990%8.797-63%2.871+15%5.413-39%
Pb Ratio2.377-414%12.22812.2280%8.131+50%5.866+108%4.190+192%
Pe Ratio-1.280+81%-6.583-6.5830%-5.528-16%-5.819-12%-4.156-37%
Price Per Share0.900-414%4.6304.6300%8.270-44%6.656-30%4.754-3%
Price To Free Cash Flow Ratio-1.495+81%-7.692-7.6920%-6.009-22%-9.106+18%-6.505-15%
Price To Total Gains Ratio-1.410+81%-7.251-7.2510%-5.616-23%4.661-256%4.661-256%
Quick Ratio--1.8411.8410%3.031-39%4.332-58%6.517-72%
Return On Assets---0.509-0.5090%-0.782+53%-0.661+30%-0.584+15%
Return On Equity---1.858-1.8580%-1.471-21%-1.540-17%-1.242-33%
Total Gains Per Share---0.639-0.6390%-1.473+131%0.000-100%0.054-1280%
Usd Book Value--62055313.01162055313.0110%166696917.710-63%210136354.978-70%174128248.220-64%
Usd Book Value Change Per Share---0.082-0.0820%-0.188+131%0.000-100%0.007-1280%
Usd Book Value Per Share--0.0480.0480%0.130-63%0.164-70%0.136-64%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.090-0.0900%-0.191+113%-0.131+46%-0.097+8%
Usd Free Cash Flow---98648841.890-98648841.8900%-225551726.358+129%-133085158.458+35%-104270963.494+6%
Usd Free Cash Flow Per Share---0.077-0.0770%-0.176+129%-0.104+35%-0.081+6%
Usd Free Cash Flow To Equity Per Share---0.074-0.0740%-0.166+125%0.010-869%0.015-585%
Usd Market Cap147497712.261-414%758793786.410758793786.4100%1355340089.333-44%1090827525.344-30%779162518.103-3%
Usd Price Per Share0.115-414%0.5910.5910%1.056-44%0.850-30%0.607-3%
Usd Profit---115271980.600-115271980.6000%-245196770.000+113%-206810098.920+79%-157846193.729+37%
Usd Revenue--61470055.10061470055.1000%31122788.600+98%45050338.020+36%32366714.300+90%
Usd Total Gains Per Share---0.082-0.0820%-0.188+131%0.000-100%0.007-1280%
 EOD+3 -5MRQTTM+0 -0YOY+19 -135Y+11 -2210Y+13 -20

3.2. Fundamental Score

Let's check the fundamental score of CStone Pharmaceuticals based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.280
Price to Book Ratio (EOD)Between0-12.377
Net Profit Margin (MRQ)Greater than0-1.875
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.841
Current Ratio (MRQ)Greater than11.317
Debt to Asset Ratio (MRQ)Less than10.726
Debt to Equity Ratio (MRQ)Less than12.646
Return on Equity (MRQ)Greater than0.15-1.858
Return on Assets (MRQ)Greater than0.05-0.509
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of CStone Pharmaceuticals based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.223
Ma 20Greater thanMa 500.903
Ma 50Greater thanMa 1001.177
Ma 100Greater thanMa 2001.679
OpenGreater thanClose0.850
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets1,638,427
Total Liabilities1,189,101
Total Stockholder Equity449,326
 As reported
Total Liabilities 1,189,101
Total Stockholder Equity+ 449,326
Total Assets = 1,638,427

Assets

Total Assets1,638,427
Total Current Assets1,246,917
Long-term Assets391,510
Total Current Assets
Cash And Cash Equivalents 415,009
Short-term Investments 623,230
Net Receivables 77,133
Inventory 22,188
Other Current Assets 105,505
Total Current Assets  (as reported)1,246,917
Total Current Assets  (calculated)1,243,065
+/- 3,852
Long-term Assets
Property Plant Equipment 206,566
Intangible Assets 159,699
Long-term Assets  (as reported)391,510
Long-term Assets  (calculated)366,265
+/- 25,245

Liabilities & Shareholders' Equity

Total Current Liabilities946,482
Long-term Liabilities242,619
Total Stockholder Equity449,326
Total Current Liabilities
Short Long Term Debt 8,567
Accounts payable 290,414
Other Current Liabilities 210,281
Total Current Liabilities  (as reported)946,482
Total Current Liabilities  (calculated)509,262
+/- 437,220
Long-term Liabilities
Long term Debt Total 241,372
Long-term Liabilities  (as reported)242,619
Long-term Liabilities  (calculated)241,372
+/- 1,247
Total Stockholder Equity
Common Stock802
Retained Earnings -8,652,493
Capital Surplus 8,627,932
Other Stockholders Equity 473,087
Total Stockholder Equity (as reported)449,326
Total Stockholder Equity (calculated)449,328
+/- 2
Other
Capital Stock802
Cash And Equivalents3,852
Cash and Short Term Investments 1,042,091
Common Stock Shares Outstanding 1,198,744
Liabilities and Stockholders Equity 1,638,427
Net Invested Capital 676,879
Net Working Capital 300,435
Property Plant and Equipment Gross 260,328



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
826,139
564,280
1,632,118
2,950,645
3,762,752
2,271,453
1,638,427
1,638,4272,271,4533,762,7522,950,6451,632,118564,280826,139
   > Total Current Assets 
824,816
545,260
1,604,948
2,886,843
3,572,303
1,957,645
1,246,917
1,246,9171,957,6453,572,3032,886,8431,604,948545,260824,816
       Cash And Cash Equivalents 
59,539
83,390
701,336
1,126,436
3,024,548
742,724
415,009
415,009742,7243,024,5481,126,436701,33683,39059,539
       Short-term Investments 
752,388
454,303
856,628
1,616,188
368,995
983,615
623,230
623,230983,615368,9951,616,188856,628454,303752,388
       Net Receivables 
760
0
0
0
0
117,598
77,133
77,133117,5980000760
       Inventory 
0
0
0
0
0
61,363
22,188
22,18861,36300000
   > Long-term Assets 
1,323
19,020
27,170
63,802
190,449
313,808
391,510
391,510313,808190,44963,80227,17019,0201,323
       Property Plant Equipment 
1,034
15,457
14,473
22,226
101,953
187,923
206,566
206,566187,923101,95322,22614,47315,4571,034
       Intangible Assets 
9
222
897
1,305
6,509
70,539
159,699
159,69970,5396,5091,3058972229
       Other Assets 
280
3,341
11,800
43,843
117,398
57,284
0
057,284117,39843,84311,8003,341280
> Total Liabilities 
59,184
113,228
1,116,787
469,063
808,292
1,064,445
1,189,101
1,189,1011,064,445808,292469,0631,116,787113,22859,184
   > Total Current Liabilities 
59,184
113,228
1,109,222
457,964
727,049
932,948
946,482
946,482932,948727,049457,9641,109,222113,22859,184
       Short-term Debt 
752,388
454,303
856,628
1,616,188
2,662
0
0
002,6621,616,188856,628454,303752,388
       Short Long Term Debt 
0
0
0
0
2,662
30,700
8,567
8,56730,7002,6620000
       Accounts payable 
0
302
4,559
37,304
28,030
414,293
290,414
290,414414,29328,03037,3044,5593020
       Other Current Liabilities 
9,293
92,348
1,046,629
103,900
7,210
74,053
210,281
210,28174,0537,210103,9001,046,62992,3489,293
   > Long-term Liabilities 
0
0
7,565
11,099
81,243
131,497
242,619
242,619131,49781,24311,0997,56500
       Long term Debt Total 
0
0
0
0
72,545
130,250
241,372
241,372130,25072,5450000
       Other Liabilities 
0
0
7,565
11,099
8,698
1,247
0
01,2478,69811,0997,56500
> Total Stockholder Equity
712,688
426,338
515,331
2,481,582
2,954,460
1,207,008
449,326
449,3261,207,0082,954,4602,481,582515,331426,338712,688
   Common Stock
26
26
29
687
787
796
802
802796787687292626
   Retained Earnings 
-246,091
-554,995
-2,300,272
-4,608,716
2,953,692
-7,749,815
-8,652,493
-8,652,493-7,749,8152,953,692-4,608,716-2,300,272-554,995-246,091
   Capital Surplus 
706,710
706,710
2,685,871
6,651,201
8,324,313
8,464,602
8,627,932
8,627,9328,464,6028,324,3136,651,2012,685,871706,710706,710
   Treasury Stock00-19-30000
   Other Stockholders Equity 
251,994
274,548
129,609
438,440
2,953,692
491,436
473,087
473,087491,4362,953,692438,440129,609274,548251,994



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in HKD. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue481,363
Cost of Revenue-202,985
Gross Profit278,378278,378
 
Operating Income (+$)
Gross Profit278,378
Operating Expense-1,384,871
Operating Income-894,201-1,106,493
 
Operating Expense (+$)
Research Development614,162
Selling General Administrative576,363
Selling And Marketing Expenses-
Operating Expense1,384,8711,190,525
 
Net Interest Income (+$)
Interest Income8,477
Interest Expense-9,136
Other Finance Cost-1,854
Net Interest Income1,195
 
Pretax Income (+$)
Operating Income-894,201
Net Interest Income1,195
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-902,678-894,201
EBIT - interestExpense = -9,136
-902,678
-893,542
Interest Expense9,136
Earnings Before Interest and Taxes (EBIT)--893,542
Earnings Before Interest and Taxes (EBITDA)-849,661
 
After tax Income (+$)
Income Before Tax-902,678
Tax Provision--
Net Income From Continuing Ops-902,678-902,678
Net Income-902,678
Net Income Applicable To Common Shares-902,678
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--1,195
 

Technical Analysis of CStone Pharmaceuticals
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of CStone Pharmaceuticals. The general trend of CStone Pharmaceuticals is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine CStone Pharmaceuticals's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of CStone Pharmaceuticals.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.11 < 1.11 < 1.35.

The bearish price targets are: 0.8.

Tweet this
CStone Pharmaceuticals Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of CStone Pharmaceuticals. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

CStone Pharmaceuticals Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of CStone Pharmaceuticals. The current macd is -0.08644233.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the CStone Pharmaceuticals price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for CStone Pharmaceuticals. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the CStone Pharmaceuticals price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
CStone Pharmaceuticals Daily Moving Average Convergence/Divergence (MACD) ChartCStone Pharmaceuticals Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of CStone Pharmaceuticals. The current adx is 33.10.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell CStone Pharmaceuticals shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
CStone Pharmaceuticals Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of CStone Pharmaceuticals. The current sar is 1.01869055.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
CStone Pharmaceuticals Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of CStone Pharmaceuticals. The current rsi is 41.22. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
CStone Pharmaceuticals Daily Relative Strength Index (RSI) ChartCStone Pharmaceuticals Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of CStone Pharmaceuticals. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the CStone Pharmaceuticals price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
CStone Pharmaceuticals Daily Stochastic Oscillator ChartCStone Pharmaceuticals Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of CStone Pharmaceuticals. The current cci is -35.28319406.

CStone Pharmaceuticals Daily Commodity Channel Index (CCI) ChartCStone Pharmaceuticals Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of CStone Pharmaceuticals. The current cmo is -3.99730053.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
CStone Pharmaceuticals Daily Chande Momentum Oscillator (CMO) ChartCStone Pharmaceuticals Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of CStone Pharmaceuticals. The current willr is -56.52173913.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that CStone Pharmaceuticals is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
CStone Pharmaceuticals Daily Williams %R ChartCStone Pharmaceuticals Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of CStone Pharmaceuticals.

CStone Pharmaceuticals Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of CStone Pharmaceuticals. The current atr is 0.08714702.

CStone Pharmaceuticals Daily Average True Range (ATR) ChartCStone Pharmaceuticals Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of CStone Pharmaceuticals. The current obv is -50,720,466.

CStone Pharmaceuticals Daily On-Balance Volume (OBV) ChartCStone Pharmaceuticals Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of CStone Pharmaceuticals. The current mfi is 49.46.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
CStone Pharmaceuticals Daily Money Flow Index (MFI) ChartCStone Pharmaceuticals Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for CStone Pharmaceuticals.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-11-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-19BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-29MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-19MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-03-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-05RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

CStone Pharmaceuticals Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of CStone Pharmaceuticals based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.223
Ma 20Greater thanMa 500.903
Ma 50Greater thanMa 1001.177
Ma 100Greater thanMa 2001.679
OpenGreater thanClose0.850
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of CStone Pharmaceuticals with someone you think should read this too:
  • Are you bullish or bearish on CStone Pharmaceuticals? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about CStone Pharmaceuticals? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about CStone Pharmaceuticals

I send you an email if I find something interesting about CStone Pharmaceuticals.


Comments

How you think about this?

Leave a comment

Stay informed about CStone Pharmaceuticals.

Receive notifications about CStone Pharmaceuticals in your mailbox!